A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma

Clinical trial NCT07402876 · RECRUITING

Trial details

NCT number: NCT07402876
Sponsor: Aldeyra Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Vitreoretinal Lymphoma

Start date: 2026-02-01
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.